LCOR had been identified as a tumor suppressor in prostate cancer [62] and a recent study showed that the miR-199a-LCOR-IFN axis is a critical regulator maintaining the stem cell phenotype in breast cancer [63]. This evidence concerns the gene LCOR and neoplasm.